BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2014
View Archived Issues
Whole-exome sequencing links motor neuron disease and neurodegenerative disorders
Read More
Zenith Epigenetics identifies new compounds for epigenetics drug discovery
Read More
Catalyst Biosciences presents new polypeptides for coagulation disorders
Read More
FDA grants orphan drug status to "lost" drug for AML
Read More
Prana Biotechnology reports phase II results in Huntington's disease trial
Read More
Researchers at Biogen Idec prepare novel autotaxin inhibitors
Read More
Elite Pharmaceuticals reports data from pilot bioequivalence study of ELI-201
Read More
Supplemental NDA for Lymphoseek granted priority review by FDA
Read More
New seriniquinone derivatives with utility for cancer
Read More
Servier Canada invests in two research projects supported by Quebec government
Read More
French group discloses novel CYP26A1 inhibitors for dermatological disorders
Read More
RaQualia Pharma collaborates with Nagoya University
Read More
Millennium Pharmaceuticals synthesizes new UBA6 inhibitors for cancer
Read More
CNB-001 demonstrates promising neuroprotective activity in vivo
Read More
Genfit's GFT-505 granted FDA fast track designation
Read More
Boehringer Ingelheim divulges novel PDE2A inhibitors
Read More
Dynavax withdraws European marketing application for Heplisav
Read More
Japanese researchers design new delta opioid receptor agonists
Read More
Vital Therapies enrolls first subject in Europe in VTI-208 study
Read More
DNA hypermethylation associated with shortened PFS in patients with RCC
Read More
Second phase Ib trial of OMP-54F28 with Nexavar in HCC begins
Read More
International Stem Cell Corp. and FDA hold pre-IND meeting for Parkinson's disease cell therapy
Read More
FDA grants accelerated approval to Northera in symptomatic NOH
Read More
Eleven Biotherapeutics begins pivotal phase III study of EBI-005
Read More
FDA approves California Stem Cell's phase II stem trial for ovarian cancer
Read More